Gut Microbiota and AUD

Recent studies indicate that gut microbiota plays a crucial role in the pathophysiology of AUD. Chronic alcohol consumption disrupts the balance of gut bacteria, leading to:

• Reduced microbial diversity

• Impaired gut barrier function

• Increased systemic inflammation

These changes can exacerbate neuroinflammation and stress dysregulation, complicating recovery efforts.

According to the World Health Organization (WHO) Global Status Report on Alcohol and Health, an estimated 2.3 billion people are current alcohol drinkers, consuming an average of 32.8 grams of pure alcohol per day (World Health Organization (WHO), 2018). Alcohol is a leading cause of AALDs globally, contributing to conditions such as steatosis, alcoholic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Despite the significant public health concern, AUD remains undertreated, and current Food and Drug Administration (FDA)-approved medications offer only modest efficacy (Huang et al., 2023).

Potential Treatment Strategies

Research is exploring innovative strategies to restore gut health, which may improve AUD outcomes. These include:

• Microbiota-targeted therapies: Aiming to restore microbial balance.

• Personalized medicine approaches: Tailoring treatments based on individual microbiota profiles.

• Integrated treatment models: Combining various therapeutic strategies for a holistic approach.

The review summarizes findings from various studies on the gut microbiome in individuals with AUD focusing on differences compared to controls and the effects of abstinence. In terms of differences between AUD individuals and controls, several studies found no differences in alpha diversity. Despite this, several studies identified imbalances in bacteria, particularly a decrease in Ruminococcaceae, and a marked decrease in Faecalibacterium prausnitzii, known for its anti-inflammatory properties (Bjorkhaug et al., 2019; Jiao et al., 2022). AUD patients showed a consistent proinflammatory profile (Dubinkina et al., 2015).

Interestingly, short-term abstinence (two to six weeks) resulted in changes in the gut microbiome, such as increased microbial diversity and some studies defined improvements in microbial translocation markers (Donnadieu-Rigole et al., 2018; Leclercq et al., 2020). Notably, the impact of short-term abstinence on the levels of Faecalibacterium prausnitzii varied across studies (Gao et al., 2020; Leclercq et al., 2020).

Clinically, gut dysbiosis was associated with a behavioral profile linked to AUD relapse, including higher alcohol craving, depression, anxiety symptoms and lower sociability, even after short-term abstinence (Leclercq et al., 2020). Remarkably, the majority of participants in these studies were male and hospitalized for AUD treatment, raising questions about generalizability to non-treatment seekers and females. Additionally, many studies had small sample sizes and lacked diversity in race and ethnicity representation, highlighting the need for larger, more diverse populations in future research.

Future Directions in AUD Treatment

The exploration of gut microbiota in AUD treatment represents a new frontier in addiction recovery. By focusing on the gut-brain axis and its influence on addiction, researchers hope to develop more effective, personalized treatment options that address the underlying biological factors of AUD. This shift towards understanding the microbiome could transform how AUD is managed, offering hope for improved recovery outcomes.

Recent research suggests that microbiota-targeted strategies may transform the management of alcohol use disorder (AUD), focusing on restoring microbial balance to improve treatment outcomes. These approaches include the use of probiotics and faecal microbiota transplantation, which have shown potential in enhancing gut health and reducing alcohol cravings during withdrawal therapy.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11305903/